Luskin, M. R., Murakami, M. A., Keating, J. H., Wang, E. S., McMasters, M., Flamand, Y., Winer, E. S., Stahl, M., Smith, H., Jaeckle, S. L., Weizer, C., Fleming, J. D., Saygin, C., Stock, W., DeAngelo, D. J. (2025). A phase I study of asciminib in combination with dasatinib, prednisone, and blinatumomab for Ph-positive acute leukemia in adults.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.6509